Evidence map›Paper›PMID 20306120›Full record

ReviewPharmaceutical research2010

Apigenin: a promising molecule for cancer prevention.

Sanjeev Shukla, Sanjay Gupta

Registry-linked trialOpen access · greenAbstract readReview
In one paragraph

Review in Pharmaceutical research, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06560216 (Effects of Supplementation of Cryopreservation Medium With Apigenin on Post-thaw Human Sperm), which is not on this map. Cited by 275 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
275citing papers in PubMed, 3 pooled it
25.5field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06560216 nacompletednot on this mapstarted 2024, after this paper: background citation

Effects of Supplementation of Cryopreservation Medium With Apigenin on Post-thaw Human Sperm

TypeinterventionalSponsorChulalongkorn UniversityRan2024 to 2025Enrolled57ConditionsHealthyArmsApigenin
3 · Its place in the literature

Who cites it

275 citing papers in PubMed, 3 syntheses or guidelines pooled it, 798 citations in OpenAlex.

  1. Necroptosis in pancreatic cancer: Molecular mechanisms and therapeutic implications.Apoptosis : an international journal on programmed cell death · 2026
    Pooled it
  2. Pooled it
  3. Pooled it
  4. Review
  5. Metabolomic, in vitro and preclinical evaluation of Auricularia polytricha mushroom.International microbiology : the official journal of the Spanish Society for Microbiology · 2026
    Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Review
  15. Flavonoids as colchicine binding site inhibitors: emerging scaffolds in anticancer drug design.Medicinal chemistry research : an international journal for rapid communications on design and mechanisms of action of biologically active agents · 2026
    Review
  16. Review
  17. Article
  18. Review
  19. Frontiers in veterinary science · 2026
    Article
  20. Review

215 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Sanjeev ShuklaDepartment of Urology, Case Western Reserve University, 10900 Euclid Avenue, Cleveland, Ohio 44106, USA.
Sanjay Gupta
Case Western Reserve University · USUniversity Hospitals Case Medical Center · US

Funding

Prostate Cancer Chemoprevention by ApigeninR01CA108512 · NCI · CASE WESTERN RESERVE UNIVERSITY · PI GUPTA, SANJAY · 2004 to 2014
$2.4M
Chamomile as Medicine for Prostate cancerR01AT002709 · NCCIH · CASE WESTERN RESERVE UNIVERSITY · PI GUPTA, SANJAY · 2005 to 2009
$1.3M
FOXO: A Target for Prostate Cancer PreventionR03CA137667 · NCI · CASE WESTERN RESERVE UNIVERSITY · PI SHUKLA, SANJEEV · 2009 to 2010
$157k
NCCIH NIH HHS R01 AT002709NCI NIH HHS R01 CA108512NCI NIH HHS R03 CA137667
6 · The paper itself

Abstract

Apigenin, a naturally occurring plant flavone, abundantly present in common fruits and vegetables, is recognized as a bioactive flavonoid shown to possess anti-inflammatory, antioxidant and anticancer properties. Epidemiologic studies suggest that a diet rich in flavones is related to a decreased risk of certain cancers, particularly cancers of the breast, digestive tract, skin, prostate and certain hematological malignancies. It has been suggested that apigenin may be protective in other diseases that are affected by oxidative process, such as cardiovascular and neurological disorders, although more research needs to be conducted in this regard. Human clinical trials examining the effect of supplementation of apigenin on disease prevention have not been conducted, although there is considerable potential for apigenin to be developed as a cancer chemopreventive agent.

Indexed as

AnimalsAnticarcinogenic AgentsApigeninHumansNeoplasmsAnticarcinogenic AgentsApigenin

Identifiers

PMID20306120
PMCPMC2874462
OpenAlexW2074951329

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.